‘ “The Crucifixion of Brother Peter”: Moral Claims and Religious Imagery in Two Competing Narratives about the Cochrane Collaboration’ – 17 February 2020

In 2018, a so-called crisis developed in the Cochrane network of systematic reviewers. It was widely depicted in terms of two competing narratives – [a] “bad behaviour” by one individual and [b] scientific and moral decline within Cochrane. This presentation will report the attempt of an interdisciplinary group of scholars (from medicine, sociology, critical management studiesContinue reading “‘ “The Crucifixion of Brother Peter”: Moral Claims and Religious Imagery in Two Competing Narratives about the Cochrane Collaboration’ – 17 February 2020”

‘We are not good at translating lab science into new medicines for patients’ – 20 January 2020

The discovery of “pioneer medicines” (i.e. those acting via novel molecular targets) has proven to be an immensely complex, long term, expensive and high risk endeavour. Despite formidable investments by the pharmaceutical industry and public/ charitable funders, over the past few decades in both infrastructure and technology, the success rates have remained low. During his presentation,Continue reading “‘We are not good at translating lab science into new medicines for patients’ – 20 January 2020”